EWA
RCUS icon

EverSource Wealth Advisors’s Arcus Biosciences RCUS Stock Holding History

EverSource Wealth Advisors’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.85K Sell
317
-120
-27% -$2.59K ﹤0.01% 3109
2025
Q4 		$10.4K Hold
437
– – ﹤0.01% 2773
2025
Q3 		$5.94K Buy
437
+133
+44% +$1.38K ﹤0.01% 3081
2025
Q2 		$2.48K Buy
304
+289
+1,927% +$2.47K ﹤0.01% 3434
2025
Q1 		$118 Sell
15
-6
-29% -$70 ﹤0.01% 3803
2024
Q4 		$313 Buy
21
+13
+163% +$212 ﹤0.01% 3334
2024
Q3 		$122 Buy
+8
New +$126 ﹤0.01% 2975
2024
Q1 		– Sell
-108
Closed -$2.06K – 2975
2023
Q4 		$2.06K Buy
+108
New +$1.73K ﹤0.01% 2153

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

EverSource Wealth Advisors's RCUS Position: Q1 2026 in Review

EverSource Wealth Advisors reduced its Arcus Biosciences (RCUS) stake by 27% in Q1 2026, selling an estimated $2.59K and leaving 317 shares worth $6.85K. The position accounts for ﹤0.01% of the portfolio, ranked #3109.

EverSource Wealth Advisors first reported a position in RCUS in Q4 2023 and has held it in 8 quarters since. The position peaked at $10.4K in Q4 2025. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

  • EverSource Wealth Advisors held 317 shares of Arcus Biosciences worth $6.85K as of Q1 2026.
  • EverSource Wealth Advisors sold 120 Arcus Biosciences shares in Q1 2026, an estimated $2.59K.
  • Arcus Biosciences made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q1 2026, its #3109 holding.
  • EverSource Wealth Advisors first reported a position in Arcus Biosciences in Q4 2023 and has held it in 8 quarters since.
  • EverSource Wealth Advisors's Arcus Biosciences position peaked at $10.4K in Q4 2025.
  • 210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on EverSource Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.